Patents
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
01/2004
01/22/2004CA2492297A1 Steroid conjugates, preparation thereof and the use thereof
01/21/2004EP1382605A2 8-azabicyclo(3.2.1)oct-2-ene derivatives and their use as nAChR ligands
01/21/2004EP1382332A1 Method for inhibiting bacterial or fungal growth using a polyamine derivative as complexing agent
01/21/2004EP1381839A2 Method of imaging cell death in vivo
01/21/2004EP1381604A2 Amyloid plaque aggregation inhibitors and diagnostic imaging agents
01/21/2004EP1381397A2 Stabilisation of radiopharmaceutical compositions using a hydrophilic thioether or a hydrophilic 6-hydroxy chroman
01/21/2004EP1381396A2 Tc and re labeled radioactive glycosylated octreotide derivatives
01/21/2004EP1381395A2 Systems, methods and devices for in vivo monitoring of a localized response via a radiolabeled analyte in a subject
01/21/2004EP1149095B1 Novel azabicyclo derivatives and their use
01/21/2004CN1469746A A retroviral immunotherapy
01/21/2004CN1469720A Radioactive emission detector with position tracking system and application in therapeutical system and treatment process
01/20/2004US6680328 Cholinergic ligands of nicotinic acetyl choline receptors for treatment of central nervous system disorders, smooth muscle contraction disorders, endocrine diseases/disorders, neurodegeneration, inflammation, pain, and drug withdrawal
01/20/2004US6680320 Urokinase inhibitors
01/20/2004US6680047 Diagnostic/therapeutic agents
01/20/2004US6680045 Melanotropin analogs for potential radiopharmaceuticals for diagnosis and treatment of melanoma
01/20/2004US6679824 Products and methods for brachytherapy
01/15/2004WO2004005320A2 ErbB-2 RECEPTOR TARGETING PEPTIDE
01/15/2004WO2004004787A2 Method and device for dispensing individual doses of a radiopharmaceutical solution
01/15/2004WO2004004635A2 Radiolabeled compounds and liposomes and their methods of making and using the same
01/15/2004WO2003057148A3 Use of biomolecular targets in the treatment and visualization of tumors
01/15/2004WO2002086093A3 Methods of using a hyaluronan receptor
01/15/2004US20040010811 Mixture comprising modulator for cancer activity; anticarcinogenic agents; tumor diagnosis; immunotherapy
01/15/2004US20040010127 Rhenium and technetium complexes containing a hypoxia-localizing moiety
01/15/2004US20040009955 Combating metastatic bone cancer with a polyphosphonate and a soluble radium-223 or - 224 salt or complex.
01/15/2004US20040009122 A formulation V-L-R where v is a vector moiety having affinity for an angiogenesis-related endothelial cell receptor, L is a linker or a bond and R is a detectable moiety (v is nonpeptidic or peptide and R is a macromolecule)
01/15/2004CA2490959A1 Radiolabeled compounds and liposomes and their methods of making and using the same
01/14/2004EP1379499A1 New diaminedithiol derivatives and radiorhenium or radiotechnetium complex thereof; a liver cancer-treating composition comprising the radiorhenium complex and lipiodol; and a kit for preparation of the liver cancer-treating composition
01/14/2004EP1379337A1 Generation of pharmaceutical agent particles using focused acoustic energy
01/14/2004CN1468259A Immunotherapy for chronic myelocytic leukemia
01/14/2004CN1468234A Perfluoroalkyl-containing complexes with sugar radicals, process for their production and their use
01/14/2004CN1468227A Non-imidazole aryloxyalkylamines
01/14/2004CN1468221A Non-imidazole aryloxypiperidines
01/14/2004CN1468113A Complexes containing perfluoroalkyl with polar radicals, method for the production and use thereof
01/13/2004US6677454 Piperidine monoamine transporter ligands, comprising functional group capable of chelating radionuclides
01/13/2004US6677338 Serotonin transport inhibitors
01/13/2004US6676988 Radioactively coated devices
01/13/2004US6676929 Medical diagnosis; gadofosveset
01/13/2004US6676926 Radiopharmaceuticals for diagnosing Alzheimer's disease
01/13/2004US6676924 CDR-grafted type III anti-CEA humanized mouse monoclonal antibodies
01/08/2004WO2004003166A2 Antibodies and uses thereof
01/08/2004WO2004003155A2 Humanized anti-tag-72 cc49 for diagnosis and therapy of human tumors
01/08/2004WO2004003016A2 Marked peptides having affinity for a phospholipid and uses
01/08/2004WO2004002984A2 Marked maleimide compounds, method for preparing same and use thereof for marking macromolecules
01/08/2004WO2004002528A1 Compositions and methods for therapeutic treatment
01/08/2004WO2004002455A1 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system
01/08/2004WO2004002401A2 Caspase inhibitors for the treatment of diseases and conditions caused by exposure to radionuclides, biological agents, or chemical agents
01/08/2004WO2004002308A2 Management of gastro-intestinal disorders
01/08/2004WO2004002307A2 Management of gastro-intestinal disorders
01/08/2004WO2003085093A3 Antibodies that specifically bind to gmad
01/08/2004WO2002060524A9 Enhanced ultrasound detection with temperature dependent contrast agents
01/08/2004US20040005598 Comprises nucleotide sequences coding protein upregulated in metastatic prostate cancer (PUMPCn) for diagnosis and treatment of tumors; antiproliferative agents; anticarcinogenic agents
01/08/2004US20040005324 Identification and cloning of a novel neutralizing human monoclonal antibody to the Respiratory Syncytial Virus. The invention provides such antibodies, fragments of such antibodies retaining RSV-binding ability, chimeric antibodies
01/08/2004US20040005307 Modulators of amyloid aggregation
01/08/2004DE10225932A1 Bildgebendes Verfahren und Vorrichtung zu dessen Durchführung Imaging method and device for its implementation
01/08/2004CA2492080A1 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system
01/08/2004CA2491427A1 Compositions and methods for therapeutic treatment
01/08/2004CA2491363A1 Antibodies and uses thereof
01/08/2004CA2491344A1 Marked peptides having affinity for a phospholipid and uses
01/08/2004CA2491193A1 Marked maleimide compounds, method for preparing same and use thereof for marking macromolecules
01/08/2004CA2490659A1 Humanized anti-tag-72 cc49 for diagnosis and therapy of human tumors
01/07/2004EP1377321A2 Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque
01/06/2004US6673773 Administering complex having purity of at least 95% derived from flaxseed and containing secoisolariciresinol diglucoside, cinnamic acid glucosides and hydroxymethyl glutaric acid
01/06/2004US6673347 Conjugated to polymer via schiff base, hydrazone, oxime, or azomethine compound; diagnosing tumors and metastasis
01/02/2004EP1376125A1 Radiolabeled photosensitisers for use in cancer screening
01/02/2004EP1375519A2 Method for affecting cellular function using antibodies
01/02/2004EP1374912A1 Use of metaloporphyrins for treatment of arteriosclerotic lesions
01/02/2004EP1374897A1 Chlorin and bacteriochlorin-based difunctional aminophenyl DTPA and N2S2 conjugates
01/02/2004EP1373321A2 Modified antibodies and methods of use
01/02/2004EP1372742A2 Polymeric imagable brachytherapy seed
01/02/2004EP1372741A2 Morpholino imaging and therapy
01/02/2004EP1372740A2 Methods for using annexin for detecting cell death in vivo and treating associated conditions
01/02/2004EP1372739A2 Stabilized therapeutic and imaging agents
01/02/2004EP1372724A2 Use of immunoregulatory antibodies in the treatment of neoplastic disorders
01/02/2004EP1372718A2 Production and use of novel peptide-based agents for use with bi-specific antibodies
01/02/2004EP1372694A1 Liposome targeting of matrix metalloproteinase inhibitors
01/02/2004EP1372625A1 Uses of benzylideneamino guanidines as ligands to the melanocortiin receptors
01/01/2004US20040003418 Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer
01/01/2004US20040002513 3-Substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
01/01/2004US20040001871 Lapachone delivery systems, compositions and uses related thereto
01/01/2004US20040001830 Prevention binding, coagulation; cardiovascular disorders, sepsis, antiinflammatory agents; using monoclonal antibodies
01/01/2004US20040001825 Antibody binding to glycoprotein; therapy, diagnosis of cancer
01/01/2004US20040001790 Methods for diagnosis and treatment of tumours
12/2003
12/31/2003WO2004000216A2 Anti-tenascin antibody fragments and minibodies for treatment of lymphoma
12/31/2003WO2004000205A2 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
12/31/2003WO2004000204A2 Labelled somatostatin analogs backbone cyclized through metal complexation
12/31/2003WO2003065991A3 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
12/31/2003WO2002040060A3 Conjugates of an antioxidants with metal chelating ligands
12/31/2003CN1464790A T cell receptor fusions and conjugates and methods of use thereof
12/30/2003US6670456 Actinium-225 complexes and conjugates for targeted radiotherapy
12/30/2003US6670375 Particularly, 8-aza-, 8-carbo- and 8-oxo- tropanes having 6-or 7-substituents; preferred are the dopamine transporter, the serotonin transporter and the norepinephrine transporter.
12/30/2003US6669623 One-shelled or multi-shelled nanoscalar particles composed of a core containing iron oxide and of an inner shell with groups capable of forming cationic groups which generates heat when alternating electromagnetic field applied
12/30/2003CA2001765C Chelants possessing ortho ligating functionality and complexes thereof
12/25/2003WO2003106497A1 Monoclonal antibody pam4 and its use for diagnosis and therapy of pancreatic cancer
12/25/2003WO2003106495A2 MONOCLONAL ANTIBODY hPAM4
12/25/2003US20030236417 A 4,5-Dihydro-2-(2,4-dihydroxyphenyl)-thiazole-4(S)-carboxylic acid or ester derivatives, use as iron metabolic chelators in therapeutic applications; demetallization
12/25/2003US20030236391 Imaging amyloid deposits in living patients, with an amyloid binding agents having radiolabeled iodine; radiotherapy
12/25/2003US20030236234 Diagnosis; central nervous system disorders; psychological disorders
12/25/2003US20030235843 For use as radiopharmaceuticals; solid phase synthesis; G-protein-coupled receptors
12/25/2003US20030235534 Methods and compositions for radioimmunotherapy of brain and CNS tumors
12/25/2003US20030235533 A nucleic acid sequence that is expressed by human prostate cancer cells, an expressed antigen that elicits antibodies, diagnostic kit comprising a monoclonal antibody is used to detect prostate cancer